Hana 32 Special Purpose Acquisition Company (KOSDAQ:475240)
South Korea · Delayed Price · Currency is KRW 2,100.00
-7.00 (-0.33%)
Aug 14, 2025, 1:37 PM KST
Revance Therapeutics Market Cap
KOSDAQ:475240 has a market cap or net worth of 6.77 billion as of August 14, 2025. Its market cap has decreased by -5.58% in one year.
Market Cap
6.77B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2,100.00
Market Cap Chart
Since March 27, 2024, KOSDAQ:475240's market cap has decreased from 8.00B to 6.77B, a decrease of -15.40%. That is a compound annual growth rate of -11.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 6.77B | 0.95% |
| Dec 30, 2024 | 6.70B | -16.20% |
| Mar 27, 2024 | 8.00B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KB Financial Group | 41.73T |
| Shinhan Financial Group | 33.69T |
| Hana Financial Group | 23.29T |
| Samsung Life Insurance | 22.25T |
| Meritz Financial Group | 20.20T |
| Woori Financial Group | 18.53T |
| Samsung Fire & Marine Insurance | 17.77T |
| Industrial Bank of Korea | 15.54T |